Literature DB >> 17998782

Severe versus local odontogenic bacterial infections: comparison of microbial isolates.

B Al-Nawas1, M Maeurer.   

Abstract

AIM: It was the aim of this study to evaluate the clinical and microbiological differences between severe and local odontogenic abscesses.
METHODS: Thirty patients were prospectively enrolled. Sixteen of 30 patients suffered from a severe life-threatening abscess of the head and neck, whereas 14/30 patients presented with a localized submucous abscess. Anaerobic bacteria were identified and susceptibility testing was performed using E test strips for penicillin, amoxicillin + clavulanic acid, imipenem + cilastatin, clindamycin and metronidazole.
RESULTS: The mean duration until removal of all drains was 14.1 and 3.5 days, respectively. Anaerobic bacteria were found in all episodes of local abscesses, whereas 19% of the severe episodes were culture negative, and in 13%, only aerobes were identified. A total of 60 anaerobes were isolated from 27 patients (2.2 isolates/positive sample). The dominating species were Prevotella sp. (n = 17), Peptostreptococcus sp. (n = 15) and Propionibacterium sp. (n = 5). Eighty-seven percent of the isolates were susceptible to penicillin. Ninety-seven percent of the anaerobes were susceptible to amoxicillin + clavulanic acid, imipenem + cilastatin, and clindamycin. Eighty-three percent were susceptible to metronidazol. There was a tendency for a higher rate of episodes with penicillin-resistant bacteria in the patients with severe abscesses (14 vs. 31%). No difference in susceptibility regarding amoxicillin + clavulanic acid and clindamycin (7%) was observed. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998782     DOI: 10.1159/000110864

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  7 in total

1.  [Dentogenic infections-part I: the significance of bacterial isolation of dentogenic infections under routineous conditions].

Authors:  Alexander W Eckert; Louise Just; Dorothea Wilhelms; Johannes Schubert
Journal:  Wien Med Wochenschr       Date:  2012-06-05

2.  Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.

Authors:  B Al-Nawas; C Walter; T Morbach; N Seitner; E Siegel; M Maeurer; F Krummenauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

3.  Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.

Authors:  Georg Cachovan; Rainer H Böger; Ina Giersdorf; Olaf Hallier; Thomas Streichert; Munif Haddad; Ursula Platzer; Gerhard Schön; Karl Wegscheider; Ingo Sobottka
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

4.  Mapping the microbiological diversity of odontogenic abscess: are we using the right drugs?

Authors:  Nils Heim; Benedict Jürgensen; Franz-Josef Kramer; Valentin Wiedemeyer
Journal:  Clin Oral Investig       Date:  2020-05-29       Impact factor: 3.573

5.  Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.

Authors:  Ingo Sobottka; Karl Wegscheider; Ludwig Balzer; Rainer H Böger; Olaf Hallier; Ina Giersdorf; Thomas Streichert; Munif Haddad; Ursula Platzer; Georg Cachovan
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

6.  Microbiome of Odontogenic Abscesses.

Authors:  Sebastian Böttger; Silke Zechel-Gran; Daniel Schmermund; Philipp Streckbein; Jan-Falco Wilbrand; Michael Knitschke; Jörn Pons-Kühnemann; Torsten Hain; Markus Weigel; Hans-Peter Howaldt; Eugen Domann; Sameh Attia
Journal:  Microorganisms       Date:  2021-06-16

7.  Odontogenic Cervicofacial Necrotizing Fasciitis: Microbiological Characterization and Management of Four Clinical Cases.

Authors:  Sebastian Böttger; Silke Zechel-Gran; Daniel Schmermund; Philipp Streckbein; Jan-Falco Wilbrand; Michael Knitschke; Jörn Pons-Kühnemann; Torsten Hain; Markus Weigel; Can Imirzalioglu; Hans-Peter Howaldt; Eugen Domann; Sameh Attia
Journal:  Pathogens       Date:  2022-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.